Publisher
Springer International Publishing
Reference31 articles.
1. Dalakas, M.C.: Polymyositis, dermatomyositis, and inclusion-body myositis. New Engl. J. Med. 325(21), 1487–1498 (1991)
2. Griggs, R.C., et al.: Inclusion body myositis and myopathies. Ann. Neurol. Official J. Am. Neurol. Assoc. Child Neurol. Soc. 38(5), 705–713 (1995)
3. Ghannam, K., et al.: Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNγ. PLoS One 9(8), e104048 (2014)
4. Rose, M.R.: 188th ENMC international workshop: inclusion body myositis, 2–4 December 2011, Naarden the Netherlands. Neuromusc. Disord. 23(12), 1044–1055 (2013)
5. Machado, P., et al.: Lb0002 safety and tolerability of arimoclomol in patients with sporadic inclusion body myositis: a randomized, double-blind, placebo controlled, phase IIa proof-of-concept trial. Ann. Rheum. Dis. 72(Suppl 3), A164–A164 (2013)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献